| Name | Title | Contact Details |
|---|
Circle Health Services, now affiliated with The Centers for Families and Children, is a nonprofit Federally Qualified Health Center (FQHC) that provides high-quality health care and related services to individuals and families regardless of their ability to pay. The Circle Health Services community health center, located at 12201 Euclid Avenue, is a 34,000 sq. ft. facility equipped with 18 examination rooms, five dental chairs, multiple group and individual therapy rooms, and an in-house pharmaceutical dispensary. The health center offers Adult and Pediatric Primary Care, a Teen/Reproductive Health Clinic, Dental Services, Behavioral Health Clinic, HIV Services, Dental Services, and Project DAWN (Deaths Avoided with Naloxone). Circle Health also operates a mobile syringe exchange program. Today, through its affiliation with The Centers for Families and Children, Circle Health operates under a shared leadership structure, which allows the organizations integrate behind-the-scenes administrative and operational support work and provide employees of both organizations access to the same benefits and professional development. Together, the organizations serve nearly 30,000 people and have more than 600 employees.
Total Health Care is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Occupational Health Research is a Skowhegan, ME-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Veterinary Care Group Animal Hospital in Astoria, Bayside, Forest Hills, Glen Oaks, Little Neck, Middle Village, Oyster Bay, Westbury, NY